Are Aviva plc And Prudential plc Risky Bets For 2015?

Aviva plc (LON:AV) and Prudential plc (LON:PRU) aren’t too bad, but there are better alternatives in this market, argues Alessandro Pasetti.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The most obvious question for value hunters in the insurance sector is whether Aviva (LSE: AV) (NYSE: AV.US) is a steal right now. Well, I reckon its shares are fairly attractive, although they are not a bargain. Another question is whether Prudential (LSE: PRU) will react to Aviva’s latest acquisition of Friends Life; I wouldn’t bet such an outcome, but Prudential could be a decent investment on its own.

Given the uncertain surrounding the regulatory environment, it takes courage to bet on both Aviva and Prudential, I appreciate that, but at 480p/500p a share the Aviva investment could easily deliver a 15% pre-tax return, excluding dividends, in 2015. Prudential, meanwhile, could do even better if recent trends are confirmed. 

Aviva: Too Risky For You?

Aviva is merging with Friends Life in a multi-billion deal that could boost shareholder value, although the market doesn’t believe the tie-up is in the best interest of Aviva shareholders. Aviva has been under pressure ever since the deal was announced in late November (-10% over the period), but short-term weakness in its stock price doesn’t change the investment case over the medium term, in my view.

As I recently argued, assuming a very aggressive scenario for cost synergies, the combined entity’s operating profitability will rise significantly, which will benefit cash flows and Aviva’s dividend policy. Aviva expects about £600m of incremental cash flow from the tie-up and it also expects to retain its coveted credit rating. 

Investment and financing opportunities are few and far between, so defensive M&A could be the path to follow in the insurance sector. The shares trade about 15% below the average price target from brokers, as the recent Friends Life deal caught investors and analysts off guard. 

Will Prudential Take Heed? 

Prudential is a less risky bet than Aviva. It has delivered plenty of value in the last couple of years: its stock performance reads +62% over the period. Prudential doesn’t need M&A, in my view. 

The average price target from brokers has risen by 14% in the last 12 months and, at about 1,620p a share, is still 9% above Prudential’s current stock price. Prudential could surprise investors in the next few quarters, of course.

Based on trading multiples, one may argue that Prudential stock looks fairly valued, but earnings and dividends should rise nicely in the next 12 months or so. Its valuation should continue to benefit from its geographical mix and growth prospects in Asia, a decent dividend yield as well as better returns than rivals. What’s not to like about it? 

Well, a bottom-down approach in the sector suggests caution.

Elsewhere, I don’t fancy any other players in the sector, and I appreciate you may be looking for value elsewhere, just like me!

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »